Effect of contraceptive methods on the vaginal microbiome and host immune factors
| dc.contributor.author | Serrano, Myrna G. | |
| dc.contributor.author | Edwards, David | |
| dc.contributor.author | Ahmed, Khatija | |
| dc.contributor.author | Bailey, Veronique C. | |
| dc.contributor.author | Beksinska, Mags | |
| dc.contributor.author | Edupuganti, Laahirie | |
| dc.contributor.author | Harryparsad, Rushil | |
| dc.contributor.author | D'Hellencourt, Florence L. | |
| dc.contributor.author | Meyer, Bahiah | |
| dc.contributor.author | Mehou-Loko, Celia | |
| dc.contributor.author | Radzey, Nina | |
| dc.contributor.author | Taku, Ongeziwe | |
| dc.contributor.author | Williamson, Anna-Lise | |
| dc.contributor.author | Smit, Jennifer | |
| dc.contributor.author | Spaine, Katherine | |
| dc.contributor.author | Zhu, Bin | |
| dc.contributor.author | Jefferson, Kimberly K. | |
| dc.contributor.author | Nanda, Kavita | |
| dc.contributor.author | Strauss III, Jerome F. | |
| dc.contributor.author | Morrison, Charles S. | |
| dc.contributor.author | Deese, Jennifer; Masson, Lindi; Buck, Gregory A. | |
| dc.contributor.author | Deese, Jennifer | |
| dc.contributor.author | Masson, Lindi | |
| dc.contributor.author | Buck, Gregory A. | |
| dc.date.accessioned | 2025-11-20T08:31:04Z | |
| dc.date.available | 2025-11-20T08:31:04Z | |
| dc.date.issued | 2025-08 | |
| dc.description.abstract | OBJECTIVE : The objective of this study was to assess alterations in vaginal microbiota and immune markers over the first 3 months following initiation of copper intrauterine device (copper IUD), levonorgestrel (LNG) implant, and intramuscular depot medroxyprogestone acetate (DMPA-IM). STUDY DESIGN : We included 162 participants from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which enrolled healthy, HIV-negative women seeking contraception and randomized them to a copper IUD, LNG implant, or DMPA-IM. Microbiome and immune profiles in vaginal swab samples collected at enrollment, 1 month and 3 months were analyzed. We categorized microbiome profiles as ‘‘optimal’’, ‘‘intermediate’’, or ‘‘non-optimal’’ based on established criteria [1]. We compared microbiome and immune markers across contraceptive groups and evaluated changes to 1 and 3 months. RESULTS : Copper IUD users had a more diverse vaginal microbiome and generally increased inflammatory cytokines and antimicrobial peptides over the 3-month follow-up, compared to LNG-implant and DMPA-IM users [2]. LNG-implant users had less complex vaginal microbiomes with reduced inflammation, while DMPA-IM showed little change in either microbiome composition or inflammatory markers. Copper IUD users exhibited lower microbiome stability and a higher likelihood of transitioning to less optimal profiles. In contrast, LNG-implant users showed greater stability and a higher probability of transition to optimal microbiome and immune marker profiles. CONCLUSIONS : Contraceptive methods affect the vaginal microbiome differently. Copper IUD use may lead to less favorable profiles and increased levels of some immune markers, indicating potential adverse health effects. Conversely, LNG-implant usage promotes a more favorable microbiome and immune marker balance. IMPLICATIONS : Our findings suggest that copper IUDs are associated with decreased prevalence of Lactobacillus-dominated microbiomes, higher transition rates towards less optimal microbiome and increased inflammatory profiles, which may lead to negative implications for gynecologic and reproductive health, the LNG-implant may offer positive health benefits with increased prevalence of L. crispatus-dominated microbiomes. | |
| dc.description.department | Medical Microbiology | |
| dc.description.librarian | hj2025 | |
| dc.description.sdg | SDG-03: Good health and well-being | |
| dc.description.uri | http://www.elsevier.com/locate/contraception | |
| dc.identifier.citation | Serrano, M.G., Edwards, D., Ahmed, K. et al. 2026, 'Effect of contraceptive methods on the vaginal microbiome and host immune factors', Contraception, vol. 148, art. 110936, pp. 1-8, doi : 10.1016/j.contraception.2025.110936. | |
| dc.identifier.issn | 0010-7824 (print) | |
| dc.identifier.issn | 1879-0518 (online) | |
| dc.identifier.other | 10.1016/j.contraception.2025.110936 | |
| dc.identifier.uri | http://hdl.handle.net/2263/105394 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.rights | © 2025 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). | |
| dc.subject | Copper intrauterine device (copper IUD) | |
| dc.subject | Inflammation | |
| dc.subject | Implant, and intramuscular depot medroxyprogestone acetate (DMPA-IM) | |
| dc.subject | Lactobacillus | |
| dc.subject | LNG-implant | |
| dc.subject | Vaginal microbiome | |
| dc.subject | Levonorgestrel (LNG) | |
| dc.title | Effect of contraceptive methods on the vaginal microbiome and host immune factors | |
| dc.type | Article |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
